Essa Pharma Inc. (EPIX) NASDAQ

$2.91 0.03 (1.04%)

Market Cap: $127.01M

As of 10/04/23 04:30 PM EDT. Market closed.

(EPIX)

Essa Pharma Inc. (EPIX)
NASDAQ

$2.91
0.03 (1.04%)

Market Cap: $127.01M

As of 10/04/23 04:30 PM EDT. Market closed.

as a clinical-stage pharmaceutical company founded on cutting-edge research, essa is focused on developing novel therapeutics for cancer patients. essa embraces innovation not only in our products but also in our approach. we're firmly rooted in creative and open thinking, giving us an energy and approach that makes us a different kind of pharmaceutical ... read more

as a clinical-stage pharmaceutical company founded on cutting-edge research, essa is focused on developing novel therapeutics for cancer patients. essa embraces innovation not only in our products but also in our approach. we're firmly rooted in creative and open thinking, giving us an energy and approach that makes us a different kind of pharmaceutical company. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
17
Address
.
PRICE CHART FOR ESSA PHARMA INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.71
Previous Close
$2.88
Days Range
$2.66 - $3.06
52 week range
$1.40 - $5.16
Volume
84,676
Avg. Volume (30 days)
34,048
Market Cap
$127.01M
Dividend Yield
-
P/E
-
Shares Outstanding
44,100,838
Open
$2.71
Previous Close
$2.88
Days Range
$2.66 - $3.06
52 week range
$1.40 - $5.16
Volume
84,676
Avg. Volume (30 days)
34,048
Market Cap
$127.01M
Dividend Yield
-
P/E
-
Shares Outstanding
44,100,838
FINANCIAL STATEMENTS FOR ESSA PHARMA INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ESSA PHARMA INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Parkinson David RossChief Executive OfficerDec 30, 2022 Buy$2.603,0677,97456,542Jan 05, 2023, 06:18 PM
Parkinson David RossChief Executive OfficerDec 22, 2022 Buy$2.3921,36751,06753,475Jan 05, 2023, 06:18 PM
BERGER FRANKLIN MDirectorDec 16, 2022 Sale$2.6750,000133,500800,244Jan 05, 2023, 03:41 PM
BERGER FRANKLIN MDirectorDec 15, 2022 Sale$2.8882,000235,800900,244Jan 05, 2023, 03:41 PM
BERGER FRANKLIN MDirectorDec 14, 2022 Sale$3.0025,00075,000932,244Jan 05, 2023, 03:41 PM
BERGER FRANKLIN MDirectorDec 21, 2022 Sale$2.4172,223174,401718,738Jan 05, 2023, 03:41 PM
BERGER FRANKLIN MDirectorDec 20, 2022 Sale$2.5343,617110,351756,627Jan 05, 2023, 03:41 PM
Wood David S.Chief Financial OfficerDec 30, 2022 Buy$2.608,30221,58533,343Jan 05, 2023, 03:07 PM
BIOTECH GROWTH N V10% OwnerOct 27, 2022 Buy$4.50500,0002,251,1007,879,583Oct 28, 2022, 02:57 PM
BIOTECH GROWTH N V10% OwnerOct 26, 2022 Buy$3.981,500,0005,968,5007,379,583Oct 28, 2022, 02:57 PM
BIOTECH GROWTH N V10% OwnerJul 18, 2022 Buy$3.16300,000946,7405,879,583Jul 20, 2022, 03:21 PM
BIOTECH GROWTH N V10% OwnerJul 15, 2022 Buy$3.13241,665756,7985,579,583Jul 18, 2022, 12:48 PM
BIOTECH GROWTH N V10% OwnerJul 14, 2022 Buy$2.79347,204969,4285,337,918Jul 18, 2022, 12:48 PM
Parkinson David RossChief Executive OfficerJun 30, 2022 Buy$2.964,88714,45632,108Jul 05, 2022, 01:39 PM
BIOTECH GROWTH N V10% OwnerApr 27, 2022 Sale$5.8525,100146,9254,990,714Apr 28, 2022, 12:28 PM
BIOTECH GROWTH N V10% OwnerAug 18, 2021 Buy$8.88250,0002,218,8005,015,814Aug 20, 2021, 12:43 PM
BERGER FRANKLIN MDirectorFeb 22, 2021 Buy$27.0057,0001,539,000957,244Mar 04, 2021, 06:47 PM
BERGER FRANKLIN MDirectorDec 03, 2020 Option Exercise$3.6442,207153,701900,244Jan 11, 2021, 04:42 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Parkinson David RossChief Executive Officer12/30/20227,974
Parkinson David RossChief Executive Officer12/22/202251,067
BERGER FRANKLIN MDirector12/16/2022133,500
BERGER FRANKLIN MDirector12/15/2022235,800
BERGER FRANKLIN MDirector12/14/202275,000
BERGER FRANKLIN MDirector12/21/2022174,401
BERGER FRANKLIN MDirector12/20/2022110,351
Wood David S.Chief Financial Officer12/30/202221,585
BIOTECH GROWTH N V10% Owner10/27/20222,251,100
BIOTECH GROWTH N V10% Owner10/26/20225,968,500
BIOTECH GROWTH N V10% Owner07/18/2022946,740
BIOTECH GROWTH N V10% Owner07/15/2022756,798
BIOTECH GROWTH N V10% Owner07/14/2022969,428
Parkinson David RossChief Executive Officer06/30/202214,456
BIOTECH GROWTH N V10% Owner04/27/2022146,925
BIOTECH GROWTH N V10% Owner08/18/20212,218,800
BERGER FRANKLIN MDirector02/22/20211,539,000
BERGER FRANKLIN MDirector12/03/2020153,701
Load More Insider Transactions
FUNDS WITH A POSITION IN ESSA PHARMA INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
ADAGE CAPITAL PARTNERS GP, L.L.C.1,042,5310.00612%No changeOther
ORBIMED ADVISORS LLC921,9400.05%-23.07%Other
D. E. SHAW & CO., INC.168,0500.00046%-2.42%Other
DRIEHAUS CAPITAL MANAGEMENT LLC28,3000.00096%-89.3%Growth
GEODE CAPITAL MANAGEMENT, LLC19,0390.00001%No changeOther
BLACKROCK INC.2,2610%No changeOther
CHANGE IN SHARES OUTSTANDING FOR ESSA PHARMA INC
STOCK BUYBACKS FOR ESSA PHARMA INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
06/30/2023
03/31/2023
0%
1Q
06/30/2023
12/31/2022
0.04%
2Q
06/30/2023
09/30/2022
0.04%
3Q
06/30/2023
06/30/2022
0.07%
4Q
06/30/2023
03/31/2022
0.14%
5Q
06/30/2023
12/31/2021
0.23%
6Q
06/30/2023
09/30/2021
2.28%
7Q
06/30/2023
06/30/2021
7.50%
8Q
06/30/2023
03/31/2021
20.85%
9Q
06/30/2023
12/31/2020
32.24%
10Q
Load More

Period of Report: 06/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
03/31/2023
0%
1Q
12/31/2022
0.04%
2Q
09/30/2022
0.04%
3Q
06/30/2022
0.07%
4Q
03/31/2022
0.14%
5Q
12/31/2021
0.23%
6Q
09/30/2021
2.28%
7Q
06/30/2021
7.50%
8Q
03/31/2021
20.85%
9Q
12/31/2020
32.24%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ESSA PHARMA INC
LOADING...